The Research and Development Center of Precision Medicine, 3D Medicines Inc., Shanghai, P.R. China
Biography
The Research and Development Center of Precision Medicine, 3D Medicines Inc., Shanghai, P.R. China, Specialization in EGFR; Erlotinib; Osimertinib; Lung adenocarcinoma; Circulating tumor DNA assay, EGFR Primary T790M and L858R Double Mutation Confers Clinical Benefit to Erlotinib and Resistance to Osimertinib in One Lung Adenocarcinoma Patient
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 